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BACKGROUND For late gadolinium enhancement (LGE) cardiovas-
cular magnetic resonance (CMR) assessment of atrial scar to guide
management and targeting of ablation in atrial fibrillation (AF),
an objective, reproducible method of identifying atrial scar is
required.
OBJECTIVE To describe an automated method for operator-
independent quantification of LGE that correlates with colocated
endocardial voltage and clinical outcomes.
METHODS LGE CMR imaging was performed at 2 centers, before
and 3 months after pulmonary vein isolation for paroxysmal AF (n¼
50). A left atrial (LA) surface scar map was constructed by using
automated software, expressing intensity as multiples of standard
deviation (SD) above blood pool mean. Twenty-one patients
underwent endocardial voltage mapping at the time of pulmonary
vein isolation (11 were redo procedures). Scar maps and voltage
maps were spatially registered to the same magnetic resonance
angiography (MRA) segmentation.
RESULTS The LGE levels of 3, 4, and 5SDs above blood pool mean
were associated with progressively lower bipolar voltages compared
to the preceding enhancement level (0.85  0.33, 0.50  0.22,
and 0.38  0.28 mV; P ¼ .002, P o .001, and P ¼ .048,
respectively). The proportion of atrial surface area classified as scar
(ie, 43 SD above blood pool mean) on preablation scans was
greater in patients with postablation AF recurrence than those
without recurrence (6.6% 6.7% vs 3.5% 3.0%, P ¼ .032). The
LA volume 4102 mL was associated with a significantly greater
proportion of LA scar (6.4%  5.9% vs 3.4%  2.2%; P ¼ .007).
CONCLUSIONS LA scar quantified automatically by a simple
objective method correlates with colocated endocardial voltage.
Greater preablation scar is associated with LA dilatation and AF
recurrence.
KEYWORDS Atrial fibrillation; Delayed-enhancement magnetic
resonance imaging; Radiofrequency ablation
ABBREVIATIONS 2D ¼ 2-dimensional; AF ¼ atrial fibrillation;
CMR ¼ cardiovascular magnetic resonance; ECG ¼ electrocardio
gram; LA ¼ left atrial/atrium; LGE ¼ late gadolinium
enhancement; MRA ¼ Magnetic resonance angiography; PAF ¼
paroxysmal atrial fibrillation; RF ¼ radiofrequency; SD ¼ standard
deviation
(Heart Rhythm 2013;10:1184–1191) I 2013 Heart Rhythm Society.
All rights reserved.
Introduction
Success rates for catheter ablation of atrial fibrillation (AF)
are approximately 50%–75%1 and remain largely unchanged
despite efforts to improve targeting and delivery of ablation.
Improved outcomes require better understanding of the
patient’s atrial myocardial substrate for case selection,
tailored ablation therapy, and better evaluation of the
resulting tissue injury. Several recent studies suggest that
high-spatial-resolution late gadolinium enhancement (LGE)
cardiovascular magnetic resonance (CMR) imaging can be
used to visualize preexisting atrial fibrotic change and
evaluate radiofrequency (RF) lesions.2–8
Current methods to identify atrial scar rely on operator
judgement to define the level of enhancement assigned as
scar.2–8 One approach is to look for a bimodal distribution of
intensity to define the threshold of scar as the trough between
the peaks.3 In many patients, however, the distribution of
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intensity is not bimodal, preventing this from being a
universally applicable technique. An alternative approach
is to manually select regions of scar and nonscar tissue in
order to define a patient-specific threshold above which
enhancement is defined as scar.9 However, in many patients,
scar may be patchy and different observers may choose
different regions to define scar. Despite the operator depend-
ence of these methods, visually appreciable correlations
between regions of scar and low voltage (o0.5 mV) have
been demonstrated.10,11 Furthermore, blinded scoring sys-
tems have been used to show an association between total
atrial scar and the total burden of low voltage in a given
patient, but these measures lack the ability to confirm the
colocality of scar and low voltage.11
In this study, we examine the use of the blood pool mean
as an intensity reference in an automated process that
expresses atrial myocardial intensity as multiples of standard
deviation (SD) above blood pool mean. We tested the
hypothesis that this method will identify LGE with a level
of consistency that will enable both point-by-point correla-
tion with colocalized voltage and correlation with procedural
and patient characteristics.
Methods
Patients undergoing first ablation for paroxysmal atrial fibrilla-
tion (PAF) were recruited. LGE CMR scan was performed
before and 3 months after either cryoballoon or conventional
RF ablation. A randomly selected subset of patients underwent
endocardial voltage mapping during the ablation procedure. All
CMR scans and voltage maps were performed in sinus rhythm.
Patients were followed up with electrocardiogram (ECG) and
clinical history at 3, 6, and 12 months and with 24-hour Holter
monitor at 6 months. The study was approved by the local
research ethics committees (UK). Written informed consent
was obtained. All patients included in the study had diagnostic
quality images and completed 12-month follow-up.
LGE CMR protocol
A Philips Achieva 1.5-T MRI system and a 5- or 32-element
phased-array cardiac coil was used for LGE imaging, as
described previously.3 Fifty-phase 2-dimensional (2D) cine-
determined time delay for ECG gating. The anatomic details
of the left atrium (LA) and pulmonary veins (PVs)
were obtained by using non-ECG-gated 3D spoiled
gradient-echo contrast-enhanced timing robust angiography
(CENTRA) during the first pass of 20-mL gadobenatedime-
glumine-enhanced contrast. A 3D left ventricular LGE
breath-hold sequence, approximately 9-minute postcontrast,
was used to identify optimal nulling time for the left
ventricular.
ECG-triggered, free-breathing navigator-gated whole-heart
3D spoiled gradient-echo acquisition was performed in axial
orientation, with resolution approximately 1.5  1.5  4 mm,
reconstructed to 1.25 1.25 2 mm. Complete LA coverage
was obtained with 40–50 slices. Data were acquired within
100–150-ms window for each RR interval, with a low-high
k-space ordering and spectral presaturation with inversion
recovery for fat suppression. Inversion recovery delay, deter-
mined from the Look-Locker sequence,12 was chosen to null
the myocardial signal. Navigator inflow artifact was reduced
by lowering the navigator rescale factor and positioning the
Navigator away from the right-sided PVs. Free-breathing
images acquired 12–20-minute postinjection depending on
the successful leading navigator placement, aiming for a
Navigator efficiency of430%.
Voltage mapping
Patients underwent voltage mapping either during the initial
procedure or the redo procedure for recurrent AF. The LA
segmentation was imported into Ensite NavX (St Jude Medical,
St. Paul, MN) or CARTO 3 (Biosense Webster, Diamond Bar,
CA). The LA geometry was collected by using the duodec-
apolar AFocus catheter (St Jude Medical) or 20-pole lasso
catheter (Biosense Webster). The electroanatomical geometry
was registered to the imported LA segmentation using surface
registration. Peak-to-peak voltages were collected from the 10
bipoles of the circular mapping catheter. Bipolar electrogram
amplitudes can be influenced by catheter orientation and the
direction of wave-front propagation.13 We therefore performed
additional unipolar recordings in 5 patients using a single
reference electrode within the inferior vena cava. Bipolar (16–
500 Hz) and unipolar (2–240 Hz) filter settings were used.
Automated method of scar mapping
LA segmentation was performed on a Philips Healthcare
workstation by using the maximum intensity projection view
to remove structures external to the LA blood pool. This
surface was the reference anatomy on which LGE and voltage
were compared. Automated software written in Cþþwas used
to perform rigid or nonrigid registration14 (depending on atrial
wall overlap) between the segmented magnetic resonance
angiography (MRA) and LGE surfaces.
The LA blood pool was used as a nonenhancing region
against which the LA wall enhancement could be compared
and normalized. The blood pool was identified automatically
by shrinking the LA segmentation using mathematical
morphology, and mean (MBP) and standard deviation (SDBP)
intensity of the blood pool were calculated. The maximum
LA wall intensity (ILA) was determined along the normal to
the wall at each location, 3 mm inside and outside the LA
surface15 to allow for wall thickness and minor registration
mismatch. LA wall intensities were expressed as multiples of
SDBP above the blood pool mean to provide a normalized LA
wall intensity (NLA), such that NLA ¼ (ILA − MBP)/SDBP.
Comparison of LGE and voltage
The registered voltage map was exported for offline compar-
ison with the atrial scar map. Each electrogram was assumed
to represent a region of 2-mm radius from the point of
endocardial contact, given the electrode spacing of the
catheters used. The mean intensity of the surface “cells”
within the 2-mm radius was used to compare with colocated
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voltage. Areas without a voltage point within a 2-mm radius
were not included in the analysis. These methodological
steps are summarized in Figure 1. For each patient, the mean
voltage was calculated at each integer intensity or LGE level
and compared for intensity K vs K − 1.
Ablation procedure
Procedures were performed in the fasted state. A 14-F
cryosheath (or channel sheath for RF procedures) was
inserted into the right femoral vein. Following transeptal
puncture, anatomical and voltage maps were collected.
Wide-area circumferential ablation was performed as
described elsewhere.16 Lesions were delivered via 3.5-mm
thermocool ablation catheter encircling the left and right
PVs. Alternatively, cryoballoon ablation was performed, as
previously described.17 The cryoballoon was inflated in the
antrum of each PV for double 5-minute freezes per vein.
Residual PV sleeves were mapped and targeted using a 20-
pole circular mapping catheter. No additional ablation was
performed following confirmed PV isolation.
Figure 1 Summary of the method of
automated atrial scar mapping and anato-
mical registration for correlation with
voltage distribution. From top to bottom:
Intensity of the blood pool (MBP  SDBP)
determined from the area (blue) automati-
cally selected as 1 cm within the LA wall
was used to normalize LA wall intensity
(ILA), calculated as the maximum intensity
along chords (red lines in the second
panel) perpendicular to the LA wall. The
normalized intensity (NLA) was mapped
onto the segmented 3D surface according
to a color lookup table (third panel).
Measured endocardial voltage points were
registered to the MRA segmentation (left
first panel). Each electrogram at the anno-
tated point of endocardial contact was
assumed to represent a circular region of
2-mm radius. The segmented MRA was
divided into cells from a surface mesh, and
cells within a 2-mm radius of a voltage
point were combined to provide a single
mean intensity value (fourth panel) (see
text for discussion). Integer intensity
levels were plotted against the mean of
all colocated voltage measurements. The
correlation between mean bipolar voltage
and normalized intensity from a single
patient is demonstrated (bottom panel).
LA ¼ left atrial; MRA ¼ magnetic reso-
nance angiography.
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Comparison of LGE and clinical outcomes
Paraview software (Kitware Inc, NY) was used by an
observer blinded to the location of scar to identify the LA-
PV junction on the atrial segmentation. The PV ostial region
was defined as extending 1 cm proximal and distal to the
PV-LA junction. The lowest LGE level to demonstrate a
significantly different voltage from the normal myocardium
was defined as the threshold for atrial scar. To identify
ablation-related scar, % scar in both the ostia and the LA body
was compared in pre- and postablation scans. Total LA scar,
in both pre- and postablation scans, was compared between
patients with and without AF recurrence at 12 months.
An observer blinded to patient outcome determined whether
scar was continuous around the PV circumference in post-
ablation scans. The number of PVs showing circumferential
ablation scar was compared for patients with and without AF
recurrence, and % ostial scar was compared for veins found to
be isolated or reconnected at the redo procedure.
Statistical analysis
IBM SPSS statistics package was used for statistical analysis.
Normal variables are expressed as mean  SD. Paired and
unpaired t tests were used when appropriate. Categorical
variables were compared between groups by using the χ2 test.
The Fisher exact test was used for small sample size.
Bonferroni adjustment was applied for multiple tests. The
correlation of continuous variables was with Spearman’s
correlation coefficient for skewed data. A probability ofo.05
was significant.
Results
Fifty patients underwent LGE CMR before and 3 months
after AF ablation (cryoablation: n ¼ 25; RF ablation: n ¼
25). Twenty-one had voltage mapping performed during
either the initial (n ¼ 10) or the redo (n ¼ 11) procedure.
Patient characteristics are listed in Table 1. 3D surface
reconstruction and scar maps were created for all patients
(see examples in Figures 2A and B).
Table 1 Patient demographics
Demographic All Cryo RF
RF vs
Cryo
P Value
Patients(male) 50 (31) 25 (16) 25 (15) .87
Age (y) 59.6 13.1 58.4 14.2 59.9 11.9 .70
PAF duration,
yrs
4.2 3.2 3.5 (2.7) 5.2 3.8 .09
Hypertension 40.8% 38.5% 38.9% .83
CVA/TIA 6.1% 3.8% 11.1% .30
Value disease 10.2% 15.4% 0.0% .10
CAD 12.2% 18.2% 4.0% .09
No.of AADs 1.4 0.7 1.4 0.7 1.6 0.9 .64
Diabetes 4.08% 0.00% 5.56% .22
CHADS2 1.0 5.4 0.7 0.8 1.2 1.3 .10
LA size 37.4 5.4 37.0 4.7 38.2 6.7 .50
AAD ¼ anti-arrhythmic drug; CAD ¼ coronary artery disease; Cryo ¼
cryoballoon; CVA ¼ cerebrovascular accident; PAF ¼ paroxysmal atrial
fibrillation; RF ¼ radiofrequency; TIA ¼ transient ischemic attack.
Figure 2 LGE CMR automated atrial scar mapping (left side) obtained (A) before and (B) 3 months after ablation in 6 patients, with corresponding
endocardial voltage maps registered to the MRA segmentation of the left atrium (right side). The postablation LGE maps compare well to the corresponding
endocardial voltage maps. CMR ¼ cardiovascular magnetic resonance; LGE ¼ late gadolinium enhancement; MRA ¼ magnetic resonance angiography.
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Voltage correlation
In 21 patients, 4386 bipolar voltage measurements were
made (200 per patient). LGE levels of 3, 4, and 5SD above
blood pool mean were associated with progressively lower
combined patient mean  SD bipolar voltages compared to
the preceding enhancement level (0.85  0.33, 0.50  0.22,
and 0.38  0.28 mV, P ¼ .002, P o .001, and P ¼ .048,
respectively). Figure 3 shows the relationship between voltage
and integer LGE levels for all patients (Figure 3A) without and
(Figure 3B) with prior LA ablation. Figure 3C shows the
significantly lower unipolar voltages recorded from the areas of
LGE levels of 3SD (P ¼ .04), 4SD (P ¼ .001), and 5SD (P ¼
.02) when compared to the preceding LGE level.
Pre- and postablation LGE
The LGE level of 43SD above blood pool mean was
defined as atrial scar. In preablation scans, there was no
difference in % scar between ostial and LA body regions
(P ¼ .183). In postablation scans, % scar in the ostia was
greater than in the LA body (Po .001); % scar in the ostia
was greater in post- vs preablation scans (P o .001).
LGE and patient risk factors for stroke
Patients with low, moderate, and high CHADS2 scores had
3.2%  3.2%, 4.4%  3.4%, and 7.1%  7.4% LA scar,
respectively (low vs high; P ¼ .035; Figure 4), demonstrat-
ing higher amounts of scars in patients with a high risk of
stroke; % LA scar was greater in patients with hypertension
than in patients without hypertension (10.4%  9.9% vs
5.8%  5.4%; P ¼ .04), and it correlated with patient age
(R2 ¼ .363; P ¼ .009).
LGE and outcome from AF ablation
Twenty-five of 50 patients had recurrent AF. As shown in
Figure 5, there was less preablation scar in patients without
vs with AF recurrence (1.9%  1.7% vs 5.1%  4.3%; P ¼
.033). This was not due to the increased LA size, since no
significant difference was found in LA diameter between
patients with and without AF recurrence (37  6 mm vs
36  9 mm; P ¼ .58).
In postablation scans, there was no difference in the amount
of atrial scar between patients with and without AF recurrence
(14.2  8.9 vs 12.3  7.0; P ¼ .675), nor was there a
difference in the number of veins with circumferential scar.
However, as demonstrated in Figure 6, in 21 patients who
underwent redo procedures, 63 of 84 PVs had reconnected and
a significantly higher amount of ostial scar was seen in veins,
which remained isolated compared to those that had recon-
nected (43.5%  20.7% vs 21.8%  19.5%; Po .001).
LGE and LA size
Patients were divided into those with normal LA volume
(o102 mL)18 and enlarged LA. Patients with enlarged LA had
a greater amount of atrial scar compared to those with normal
LA size (7.5% 7.2% vs 3.5% 2.9%; P ¼ .018; Figure 7).
LGE following cryoballoon vs RF ablation
There was no difference in the amount of atrial scar
following cryoballoon or RF ablation (total LA enhance-
ment: 16.5%  14.9% vs 16.1%  11.0%; P ¼ 0.93; ostial
enhancement: 23.5% 19.9% vs 25.8% 12.9%; P¼ .81).
Discussion
We report the first point-by-point comparison of LA LGE
and colocated endocardial voltage by using an objective,
Figure 3 The mean SD voltage is demonstrated for all patients at each
intensity level. Comparison is made by using paired t tests between K and
K − 1 intensity levels. This was done in (A) 10 patients who had not had any
prior ablation, (B) 11 patients who had had prior left atrial ablation, and (C)
5 patients with prior LA ablation in whom additional unipolar voltage
mapping was performed. A significant difference in bipolar and unipolar
voltages was noted between LGE levels 3, 4, and 5SD in patients both with
and without prior LA ablation. LA ¼ left atrial; LGE ¼ late gadolinium
enhancement; SD ¼ standard deviation.
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operator-independent method of identifying atrial enhance-
ment. Increasing levels of LGE correlated with lower bipolar
and unipolar voltages. Significant associations were found
between the amount of preablation LA enhancement and
patient risk factors for stroke. We also identified increased
amounts of preablation atrial scar in patients with LA
dilatation and recurrent AF following ablation. These clinical
correlates, however, are based on a limited population of 50
patients with PAF. Larger studies will subsequently be
required to confirm these results in a much broader pop-
ulation of patients, both with and without AF.
LGE CMR and voltage
In patients both with and without prior LA ablation,
increasing enhancement levels of 3, 4, and 5SD correlated
with significant reductions in both bipolar and unipolar
voltages. There was no further reduction in measured voltage
seen in regions with enhancement45SD, indicating that the
enhancement of 5SD or greater may represent fully scarred
atrial myocardium. These objective findings from colocated
data are broadly consistent with those reported in studies by
using blinded scoring systems to correlate the number of
regions containing atrial enhancement and low voltage.6,11
Furthermore, a similar association has previously been
demonstrated between overall ventricular LGE-MRI scar
mass (42SD) and endocardial voltage o1.5 mV.19
LGE CMR and stroke risk
We found significantly higher levels of scar in patients with
high CHADS2 scores, in keeping with the findings of Daccarett
et al,20 who found LGE to be an independent predictor of
cerebrovascular events. Patients with higher CHADS2 scores
have also been found to have lower atrial voltages, which
further supports our findings.21 Of note, Daccarett found
higher levels of fibrosis, which may be due to different
methods of threshold selection, or the population studied
may have had greater levels of atrial fibrosis than our PAF
population.
It remains unclear whether preexisting atrial fibrosis is
attributable to a single factor, such as AF burden, or multiple
patient factors. LGE CMR using automated atrial scar
detection may help to investigate the disparate pathological
processes, such as hypertension and age, which result in
increased stroke risk. Further studies in larger and wider
Figure 4 Total LA scar (%) LGE CMR performed preablation is higher in
patients at high risk of stroke (CHADS2 score4 2) than in patients at low
risk of stroke (CHADS2 score ¼ 0). CMR ¼ cardiovascular magnetic
resonance; LA ¼ left atrial; LGE ¼ late gadolinium enhancement.
Figure 5 Total LA scar (%) on preablation LGE CMR in 50 patients: 25 with and 25 without AF recurrence following AF ablation. Greater amounts of scar
were seen in the preablation scans of patients with AF recurrence following ablation compared to those who remained free from AF. No difference was seen
between the amounts of scar seen in postablation scans between patients with and without recurrent AF. AF¼ atrial fibrillation; CMR¼ cardiovascular magnetic
resonance; LA ¼ left atrial; LGE ¼ late gadolinium enhancement.
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populations are required to ascertain the benefits of LGE
CMR to guide anticoagulation strategies.
LGE CMR and procedural outcome
Persistent AF and increased atrial size are the only current
predictors of reduced procedural success from AF ablation in
the literature.1,22 In our PAF population with relatively
normal LA size, preexisting atrial scarring detected by
LGE CMR identified patients who were more likely to suffer
from AF recurrence following ablation. Interestingly, in our
study population there was no significant difference in atrial
size noted between patients with and without AF recurrence
following ablation (38  5 mm vs 37  6 mm; P = .536).
Although this finding requires further study in larger
populations, it is consistent with those of Akoum et al,23
who found that patients with increasing levels of preablation
fibrosis, as denoted by Utah levels 1–4, had a higher chance of
developing recurrent AF postablation. Similarly, patients with
preprocedural atrial scarring found on endocardial voltage
mapping had a significantly higher rate of procedural failure.24
LGE CMR may noninvasively identify patients with extensive
atrial scarring, unlikely to benefit from PV isolation.
LGE CMR and PV reconnection
Current techniques for AF ablation may achieve the procedural
end point of PV conduction block, without creating permanent
circumferential full thickness lesions. A method allowing
visualization of atrial scar may facilitate the development of
improved ablation techniques. Previous studies have shown that
the extent of PV antral LGE postprocedure correlates well with
lower rates of AF recurrence.11,25 Our study did not demonstrate
an association between postablation LGE and AF recurrence.
All patients requiring a redo procedure had LGE and electrical
evidence of gaps in ablation lines leading to PV reconnection.
However, not all patients with gaps had AF recurrence. This is in
keeping with several clinical studies that have identified the
presence of reconnected veins in patients free from AF who
volunteered for a restudy following AF ablation.26
Objective scar identification methods may help to stand-
ardize definitions of atrial ablation scar and explore in a
multicenter study how the extent and location of permanent
scar translates into longer term freedom from AF.
Study limitations
While experienced operators considered each data point to
represent good myocardial contact, we were unable to
confirm contact during all voltage measurements. Poor
catheter contact could lead to erroneous recordings of low
voltage at the locations of healthy myocardium. Future
studies using pressure-sensing catheters will be more accu-
rate in comparing voltage and atrial LGE. It should be noted
that our conclusion that lower endocardial voltages are
associated with higher levels of LGE is based on the 21
patients who underwent voltage mapping and not the full
cohort of 50 patients who were included in the study for
comparison with clinical outcomes.
Acknowledging the limited spatial resolution of LGE
CMR, we elected to assign enhancement levels on the basis
of the highest signal intensity on a cord through the atrial
wall, with no attempt to differentiate transmural and partial
thickness LGE.
The manual selection of regions of interest around the PV
ostia used to calculate ostial scar adds an element of
subjectivity to our methods. However, the identical region
is used to compare pre- and postablation scans, which limits
the influence of the selection on the results.
A degree of spatial error is inherent in the process of
registering a nongated MRA sequence with an ECG and
respiratory motion gated, free-breathing LGE sequence.
Similarly, a degree of registration error is present when
Figure 6 Ostial scar (%) on postablation LGE CMR compared for veins
that were isolated and veins that were reconnected at the redo AF ablation
procedure (n ¼ 21). AF ¼ atrial fibrillation; CMR ¼ cardiovascular
magnetic resonance; LGE ¼ late gadolinium enhancement.
Figure 7 Comparison of % total LA scar on preablation LGE CMR
between atria volume o102 mL and atria volume 4102 mL (n ¼ 50).
CMR ¼ cardiovascular magnetic resonance; LA ¼ left atrial; LGE ¼ late
gadolinium enhancement.
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registering the MRA sequence with the gated electroana-
tomic map collected during the AF ablation procedure.
However, despite these limitations, these methods represent
a technique that may be readily implementable in most
hospitals and provide objective data on which further
developments in the field can be based.
Conclusions
We have described a novel operator-independent technique
of atrial LGE CMR analysis identifying atrial scar that
correlates with colocalized low-voltage measurements. The
associations described between atrial LGE and clinical
factors including CHADS2 score, LA size, and AF recur-
rence highlight the potential clinical value for risk stratifica-
tion and patient selection for ablation; however, clinical
applicability of the technique requires further validation and
investigation.
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